Sweeney & Michel’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$559K Sell
5,722
-811
-12% -$65.4K 0.15% 90
2026
Q1
$492K Buy
6,533
+53
+0.8% +$3.97K 0.14% 93
2025
Q4
$511K Buy
6,480
+46
+0.7% +$3.64K 0.15% 93
2025
Q3
$513K Buy
6,434
+46
+0.7% +$3.62K 0.17% 84
2025
Q2
$496K Buy
6,388
+45
+0.7% +$3.47K 0.18% 85
2025
Q1
$434K Buy
+6,343
New +$528K 0.19% 82
2024
Q3
$551K Buy
6,464
+16
+0.2% +$1.2K 0.22% 70
2024
Q2
$451K Buy
6,448
+50
+0.8% +$3.57K 0.19% 71
2024
Q1
$469K Buy
+6,398
New +$446K 0.21% 72
2023
Q3
$526K Buy
8,867
+67
+0.8% +$4.17K 0.28% 63
2023
Q2
$559K Buy
8,800
+80
+0.9% +$4.44K 0.29% 60
2023
Q1
$466K Buy
+8,720
New +$589K 0.25% 66

Other funds holding MET

Sweeney & Michel's MET Position: Q2 2026 in Review

Sweeney & Michel reduced its MetLife (MET) stake by 12% in Q2 2026, selling an estimated $65.4K and leaving 5,722 shares worth $559K. The position accounts for 0.15% of the portfolio, ranked #90.

Sweeney & Michel first reported a position in MET in Q1 2023 and has held it in 12 quarters since. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Sweeney & Michel held 5,722 shares of MetLife worth $559K as of Q2 2026.
  • Sweeney & Michel sold 811 MetLife shares in Q2 2026, an estimated $65.4K.
  • MetLife made up 0.15% of Sweeney & Michel's portfolio in Q2 2026, its #90 holding.
  • Sweeney & Michel first reported a position in MetLife in Q1 2023 and has held it in 12 quarters since.
  • 1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Sweeney & Michel's 13F filing for Q2 2026, filed 11 Aug 2026.